[1] Dixon S J, Lemberg K M, Lamprecht M R, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death [J]. Cell, 2012, 149 (5): 1060-1072.
[2] Bogacz M, Krauth-Siegel R L. Tryparedoxin peroxidase-deficiency commits trypanosomes to ferroptosis-type cell death [J]. eLife, 2018, 7: e37503.
[3] Jiang X, Stockwell B R, Conrad M. Ferroptosis: mechanisms, biology and role in disease [J]. Nature Reviews Molecular Cell Biology, 2021, 22 (4): 266-282.
[4] Cao J Y, Dixon S J. Mechanisms of ferroptosis [J]. Cellular and Molecular Life Sciences, 2016, 73 (11/12): 2195-2209.
[5] Friedmann Angeli J P, Schneider M, Proneth B, et al. Inactivation of the ferroptosis regulator Gpx4 triggers acute renal failure in mice [J]. Nature Cell Biology, 2014, 16 (12): 1180-1191.
[6] Bersuker K, Hendricks J M, Li Z, et al. The CoQ oxidoreductase FSP1 acts parallel to GPX4 to inhibit ferroptosis [J]. Nature, 2019, 575 (7784): 688-692.
[7] Kraft V A N, Bezjian C T, Pfeiffer S, et al. GTP cyclohydrolase 1/tetrahydrobiopterin counteract ferroptosis through lipid remodeling [J]. ACS Central Science, 2020, 6 (1): 41-53.
[8] Mao C, Liu X, Zhang Y, et al. DHODH-mediated ferroptosis defence is a targetable vulnerability in cancer [J]. Nature, 2021, 593 (7860): 586-590.
[9] Koppula P, Zhuang L, Gan B. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy [J]. Protein & Cell, 2021, 12 (8): 599-620.
[10] Bridges R J, Natale N R, Patel S A. System xc⁻-cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS [J]. British Journal of Pharmacology, 2012, 165 (1): 20-34.
[11] Lu S C. Regulation of glutathione synthesis [J]. Molecular Aspects of Medicine, 2009, 30 (1/2): 42-59.
[12] Doll S, Freitas F P, Shah R, et al. FSP1 is a glutathione-independent ferroptosis suppressor [J]. Nature, 2019, 575 (7784): 693-698.
[13] Li W, Liang L, Liu S, et al. FSP1: a key regulator of ferroptosis [J]. Trends in Molecular Medicine, 2023, 29 (9): 753-764.
[14] Mishima E, Conrad M. Nutritional and metabolic control of ferroptosis [J]. Annual Review of Nutrition, 2022, 42: 275-309.
[15] Soula M, Weber R A, Zilka O, et al. Metabolic determinants of cancer cell sensitivity to canonical ferroptosis inducers [J]. Nature Chemical Biology, 2020, 16 (12): 1351-1360.
[16] Liang D, Feng Y, Zandkarimi F, et al. Ferroptosis surveillance independent of GPX4 and differentially regulated by sex hormones [J]. Cell, 2023, 186 (13): 2748-2764.e22.
[17] Cao J, Chen X, Chen L, et al. DHODH-mediated mitochondrial redox homeostasis: a novel ferroptosis regulator and promising therapeutic target [J]. Redox Biology, 2025, 85: 103788.
[18] Zhou Y, Tao L, Zhou X, et al. DHODH and cancer: promising prospects to be explored [J]. Cancer & Metabolism, 2021, 9: 22.
[19] Munier-Lehmann H, Vidalain P O, Tangy F, et al. On dihydroorotate dehydrogenases and their inhibitors and uses [J]. Journal of Medicinal Chemistry, 2013, 56 (8): 3148-3167.
[20] Gan B. Mitochondrial regulation of ferroptosis [J]. Journal of Cell Biology, 2021, 220 (9): e202105043.
[21] Liu Y, Lu S, Wu L L, et al. The diversified role of mitochondria in ferroptosis in cancer [J]. Cell Death & Disease, 2023, 14 (8): 519.
[22] Li Y, Ran Q, Duan Q, et al. 7-Dehydrocholesterol dictates ferroptosis sensitivity [J]. Nature, 2024, 626 (7998): 411-418.
[23] Doll S, Conrad M. Iron and ferroptosis: a still ill-defined liaison [J]. IUBMB Life, 2017, 69 (6): 423-434.
[24] Kagan V E, Mao G, Qu F, et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis [J]. Nature Chemical Biology, 2017, 13 (1): 81-90.
[25] Chifman J, Laubenbacher R, Torti S V. A systems biology approach to iron metabolism [J]. Advances in Experimental Medicine and Biology, 2014, 844: 201-225.
[26] Lieu P T, Heiskala M, Peterson P A, et al. The roles of iron in health and disease [J]. Molecular Aspects of Medicine, 2001, 22 (1/2): 1-87.
[27] Gao M, Monian P, Quadri N, et al. Glutaminolysis and transferrin regulate ferroptosis [J]. Molecular Cell, 2015, 59 (2): 298-308.
[28] Henning Y, Blind U S, Larafa S, et al. Hypoxia aggravates ferroptosis in RPE cells by promoting the Fenton reaction [J]. Cell Death & Disease, 2022, 13 (7): 662.
[29] Yi Y, Zhu X, Jia P, et al. Nature’s answer to Ferroptosis: how bioactive compounds rewire oxidative stress circuits in cerebral ischemia [J]. International Immunopharmacology, 2025, 163: 115250.
[30] Hu C, Zu D, Xu J, et al. Polyphyllin B suppresses gastric tumor growth by modulating iron metabolism and inducing ferroptosis [J]. International Journal of Biological Sciences, 2023, 19 (4): 1063-1079.
[31] Xing L, Liu X Y, Zhou T J, et al. Photothermal nanozyme‑ignited Fenton reaction-independent ferroptosis for breast cancer therapy [J]. Journal of Controlled Release, 2021, 339: 14-26.
[32] Song Q, Zhang Y, Hu H, et al. Augment of ferroptosis with photothermal enhanced Fenton reaction and glutathione inhibition for tumor synergistic nano-catalytic therapy [J]. International Journal of Nanomedicine, 2024, 19: 11923-11940.
[33] Shintoku R, Takigawa Y, Yamada K, et al. Lipoxygenase‑mediated generation of lipid peroxides enhances ferroptosis induced by erastin and RSL3 [J]. Cancer Science, 2017, 108 (11): 2187-2194.
[34] Ru Q, Li Y, Xie W, et al. Fighting age-related orthopedic diseases: focusing on ferroptosis [J]. Bone Research, 2023, 11: 12.
[35] Liang D, Minikes A M, Jiang X. Ferroptosis at the intersection of lipid metabolism and cellular signaling [J]. Molecular Cell, 2022, 82 (12): 2215-2227.
[36] Li D, Li Y. The interaction between ferroptosis and lipid metabolism in cancer [J]. Signal Transduction and Targeted Therapy, 2020, 5: 108.
[37] Harayama T, Riezman H. Understanding the diversity of membrane lipid composition [J]. Nature Reviews Molecular Cell Biology, 2018, 19 (5): 281-296.
[38] Ding X, Cui L, Mi Y, et al. Ferroptosis in cancer: revealing the multifaceted functions of mitochondria [J]. Cellular and Molecular Life Sciences, 2025, 82 (1): 277.
[39] Khan M S, Hu Q, Okeibunor K, et al. Targeting ferroptosis for neuroprotection: potential therapeutic avenues in neurodegenerative and neuropsychiatric diseases [J]. Frontiers in Physiology, 2025, 16: 1641323.
[40] Han B, Zheng R, Zeng H, et al. Cancer incidence and mortality in China, 2022 [J]. Journal of the National Cancer Center, 2024, 4 (1): 47-53.
[41] Brown R A M, Richardson K L, Kabir T D, et al. Altered iron metabolism and impact in cancer biology, metastasis, and immunology [J]. Frontiers in Oncology, 2020, 10: 476.
[42] Zhang C, Zhan S, He Y, et al. Inhibition of CISD2 enhances sensitivity to doxorubicin in diffuse large B-cell lymphoma by regulating ferroptosis and ferritinophagy [J]. Frontiers in Pharmacology, 2024, 15: 1482354.
[43] Yang D, Wang T, Long M, et al. Quercetin: its main pharmacological activity and potential application in clinical medicine [J]. Oxidative Medicine and Cellular Longevity, 2020, 2020: 8825387.
[44] An S, Hu M. Quercetin promotes TFEB nuclear translocation and activates lysosomal degradation of ferritin to induce ferroptosis in breast cancer cells [J]. Computational Intelligence and Neuroscience, 2022, 2022: 5299218.
[45] Lin Y S, Shen Y C, Wu C Y, et al. Danshen improves survival of patients with breast cancer and dihydroisotanshinone I induces ferroptosis and apoptosis of breast cancer cells [J]. Frontiers in Pharmacology, 2019, 10: 1226.
[46] Wen Y, Chen H, Zhang L, et al. Glycyrrhetinic acid induces oxidative/nitrative stress and drives ferroptosis through activating NADPH oxidases and iNOS, and depriving glutathione in triple-negative breast cancer cells [J]. Free Radical Biology and Medicine, 2021, 173: 41-51.
[47] Lou J S, Zhao L P, Huang Z H, et al. Ginkgetin derived from Ginkgo biloba leaves enhances the therapeutic effect of cisplatin via ferroptosis-mediated disruption of the Nrf2/HO-1 axis in EGFR wild-type non-small-cell lung cancer [J]. Phytomedicine, 2021, 80: 153370.
[48] Zhang Q, Yi H, Yao H, et al. Artemisinin derivatives inhibit non-small cell lung cancer cells through induction of ROS‑dependent apoptosis/ferroptosis [J]. Journal of Cancer, 2021, 12 (13): 4075-4085.
[49] Wang Y, Luo W, Shen S, et al. Glaucocalyxin A induces autophagy-mediated ferroptosis by targeting PRDX1 and TXNRD1 proteins in non-small cell lung cancer [J]. Phytomedicine, 2025, 148: 157280.
[50] Xu B, Zhu W J, Peng Y J, et al. Curcumin reverses the sunitinib resistance in clear cell renal cell carcinoma (ccRCC) through the induction of ferroptosis via the ADAMTS18 gene [J]. Translational Cancer Research, 2021, 10 (7): 3158-3167.
[51] Wen R J, Dong X, Zhuang H W, et al. Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2/xCT/GPX4 regulatory axis [J]. Phytomedicine, 2023, 116: 154881.
[52] Liu S, Li Y, Zeng X, et al. Burden of cardiovascular diseases in China, 1990-2016: findings from the 2016 Global Burden of Disease Study [J]. JAMA Cardiology, 2019, 4 (4): 342-352.
[53] Fang X, Ardehali H, Min J, et al. The molecular and metabolic landscape of iron and ferroptosis in cardiovascular disease [J]. Nature Reviews Cardiology, 2023, 20 (1): 7-23.
[54] 梁芳，鲁卫星，周天琪，等。基于 NR3C1/p53/SLC7A11 通路探讨龙牙楤木总皂苷及其成分楤木皂苷 A 对缺氧 / 复氧诱导的心肌细胞铁死亡的影响 [J]. 中国中医药信息杂志，2022, 29 (5): 63-68. LIANG F, LU W X, ZHOU T Q, et al. Effects of total saponins from Aralia elata and its constituent araloside A on hypoxia/reoxygenation-induced cardiomyocyte ferroptosis based on NR3C1/p53/SLC7A11 pathway [J]. Chinese Journal of Information on Traditional Chinese Medicine, 2022, 29 (5): 63-68.
[55] Xu S, Wu B, Zhong B, et al. Naringenin alleviates myocardial ischemia/reperfusion injury by regulating the nuclear factor-erythroid factor 2-related factor 2 (Nrf2)/System xc⁻/glutathione peroxidase 4 (GPX4) axis to inhibit ferroptosis [J]. Bioengineered, 2021, 12 (2): 10924-10934.
[56] 林毅，杨春启，连闻雨，等。麦冬皂苷 D 通过铁死亡途径减轻麦冬皂苷 D’ 所致心肌细胞损伤 [J]. 药学学报，2021, 56 (8): 2241-2247. LIN Y, YANG C Q, LIAN W Y, et al. Ophiopogonin D alleviates ophiopogonin D’-induced cardiomyocyte injury via ferroptosis pathway [J]. Acta Pharmaceutica Sinica, 2021, 56 (8): 2241-2247.
[57] Ordás I, Eckmann L, Talamini M, et al. Ulcerative colitis [J]. The Lancet, 2012, 380 (9853): 1606-1619.
[58] Pang X, Yan J, Lv X, et al. Excessive ultra-processed foods exposure aggravates ulcerative colitis via macrophage ferroptosis [J]. Environment International, 2025, 202: 109706.
[59] Dong S, Lu Y, Peng G, et al. Furin inhibits epithelial cell injury and alleviates experimental colitis by activating the Nrf2-Gpx4 signaling pathway [J]. Digestive and Liver Disease, 2021, 53 (10): 1276-1285.
[60] Li Y, Feng D, Wang Z, et al. Ischemia-induced ACSL4 activation contributes to ferroptosis-mediated tissue injury in intestinal ischemia/reperfusion [J]. Cell Death & Differentiation, 2019, 26 (11): 2284-2299.
[61] Guo M, Du X, Wang X. Inhibition of ferroptosis: a new direction in the treatment of ulcerative colitis by traditional Chinese medicine [J]. Journal of Ethnopharmacology, 2024, 324: 117787.
[62] Liu J, Sun L, Chen D, et al. Prdx6-induced inhibition of ferroptosis in epithelial cells contributes to liquiritin-exerted alleviation of colitis [J]. Food & Function, 2022, 13 (18): 9470-9480.
[63] Arenbaoligao, Guo X, Xiong J, et al. Kumatakenin inhibited iron-ferroptosis in epithelial cells from colitis mice by regulating the Eno3-IRP1-axis [J]. Frontiers in Pharmacology, 2023, 14: 1127931.
[64] Yang X, Sun X, Zhou F, et al. Protocatechuic acid alleviates dextran-sulfate-sodium-induced ulcerative colitis in mice via the regulation of intestinal flora and ferroptosis [J]. Molecules, 2023, 28 (9): 3775.
[65] Yan S, Yin L, Dong R. Inhibition of IEC-6 cell proliferation and the mechanism of ulcerative colitis in C57BL/6 mice by dandelion root polysaccharides [J]. Foods, 2023, 12 (20): 3800.
[66] Yu X, Li X, Xu Y, et al. Resveratrol ameliorates ulcerative colitis by upregulating Nrf2/HO-1 pathway activity: Integrating animal experiments and network pharmacology [J]. Molecular Medicine Reports, 2024, 29 (5): 77.
[67] Wang S, Liu W, Wang J, et al. Curculigoside inhibits ferroptosis in ulcerative colitis through the induction of GPX4 [J]. Life Sciences, 2020, 259: 118356.
[68] Soriano J B, Kendrick P J, Paulson K R, et al. Prevalence and attributable health burden of chronic respiratory diseases, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017 [J]. The Lancet Respiratory Medicine, 2020, 8 (6): 585-596.
[69] Chen H, Liu B, Xu P, et al. Mechanistic role of environmental toxicants in inducing cellular ferroptosis and its associated diseases [J]. Ecotoxicology and Environmental Safety, 2025, 298: 118269.
[70] Tao N, Li K, Liu J. Molecular mechanisms of ferroptosis and its role in pulmonary disease [J]. Oxidative Medicine and Cellular Longevity, 2020, 2020: 9547127.
[71] Liu X, Ma Y, Luo L, et al. Dihydroquercetin suppresses cigarette smoke induced ferroptosis in the pathogenesis of chronic obstructive pulmonary disease by activating Nrf2-mediated pathway [J]. Phytomedicine, 2022, 96: 153894.
[72] Tang X, Li Z, Yu Z, et al. Effect of curcumin on lung epithelial injury and ferroptosis induced by cigarette smoke [J]. Human & Experimental Toxicology, 2021, 40 (12_suppl): S753-S762.
[73] Liu L, Zhang Y, Wang L, et al. Scutellarein alleviates chronic obstructive pulmonary disease through inhibition of ferroptosis by chelating iron and interacting with arachidonate 15-lipoxygenase [J]. Phytotherapy Research, 2023, 37 (10): 4587-4606.
[74] Wang Y, Wan R, Peng W, et al. Quercetin alleviates ferroptosis accompanied by reducing M1 macrophage polarization during neutrophilic airway inflammation [J]. European Journal of Pharmacology, 2023, 938: 175407.
[75] Nichols E, Steinmetz J D, Vollset S E, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019 [J]. The Lancet Public Health, 2022, 7 (2): e105-e125.
[76] Wang Y, Lv M N, Zhao W J. Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases [J]. Ageing Research Reviews, 2023, 91: 102035.
[77] Yan H F, Zou T, Tuo Q Z, et al. Ferroptosis: mechanisms and links with diseases [J]. Signal Transduction and Targeted Therapy, 2021, 6: 49.
[78] Zhang H, Zhou W, Li J, et al. Senegenin rescues PC12 cells with oxidative damage through inhibition of ferroptosis [J]. Molecular Neurobiology, 2022, 59 (11): 6983-6992.
[79] Gao Y, Li J, Wu Q, et al. Tetrahydroxystilbene glycoside ameliorates Alzheimer’s disease in APP/PS1 mice via glutathione peroxidase related ferroptosis [J]. International Immunopharmacology, 2021, 99: 108002.
[80] Lan B, Ge J W, Cheng S W, et al. Extract of Naotaifang, a compound Chinese herbal medicine, protects neuron ferroptosis induced by acute cerebral ischemia in rats [J]. Journal of Integrative Medicine, 2020, 18 (4): 344-350.
[81] Zhao H, Li X, Yang L, et al. Isorhynchophylline relieves ferroptosis-induced nerve damage after intracerebral hemorrhage via miR-122-5p/TP53/SLC7A11 pathway [J]. Neurochemical Research, 2021, 46 (8): 1981-1994.
[82] Gao S, Zhou L, Lu J, et al. Cepharanthine attenuates early brain injury after subarachnoid hemorrhage in mice via inhibiting 15-lipoxygenase-1-mediated microglia and endothelial cell ferroptosis [J]. Oxidative Medicine and Cellular Longevity, 2022, 2022: 4295208.
)
